Modern Dental Group Limited

F:1MD Germany Medical Instruments & Supplies
Market Cap
$604.55 Million
€588.96 Million EUR
Market Cap Rank
#15204 Global
#1559 in Germany
Share Price
€0.63
Change (1 day)
+4.13%
52-Week Range
€0.43 - €0.66
All Time High
€0.66
About

Modern Dental Group Limited, an investment holding company, engages in production, distribution, and trading of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. The company operates through Fixed Prosthetic Devices, Removable Prosthetic Devices, and Others segments. It offers restorative dental procedures, such as crowns, bridges, and implant. The… Read more

Modern Dental Group Limited (1MD) - Net Assets

Latest net assets as of June 2025: €3.08 Billion EUR

Based on the latest financial reports, Modern Dental Group Limited (1MD) has net assets worth €3.08 Billion EUR as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.40 Billion) and total liabilities (€1.33 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €3.08 Billion
% of Total Assets 69.89%
Annual Growth Rate 5.16%
5-Year Change 20.79%
10-Year Change N/A
Growth Volatility 6.9

Modern Dental Group Limited - Net Assets Trend (2016–2024)

This chart illustrates how Modern Dental Group Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Modern Dental Group Limited (2016–2024)

The table below shows the annual net assets of Modern Dental Group Limited from 2016 to 2024.

Year Net Assets Change
2024-12-31 €2.73 Billion +3.12%
2023-12-31 €2.64 Billion +13.27%
2022-12-31 €2.33 Billion -1.07%
2021-12-31 €2.36 Billion +4.53%
2020-12-31 €2.26 Billion +11.58%
2019-12-31 €2.02 Billion +1.52%
2018-12-31 €1.99 Billion -5.36%
2017-12-31 €2.10 Billion +15.52%
2016-12-31 €1.82 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Modern Dental Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 237.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €2.21 Billion 81.21%
Other Components €510.31 Million 18.79%
Total Equity €2.72 Billion 100.00%

Modern Dental Group Limited Competitors by Market Cap

The table below lists competitors of Modern Dental Group Limited ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Modern Dental Group Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,632,279,000 to 2,715,868,000, a change of 83,589,000 (3.2%).
  • Net income of 408,002,000 contributed positively to equity growth.
  • Dividend payments of 160,659,000 reduced retained earnings.
  • Share repurchases of 25,054,000 reduced equity.
  • Other factors decreased equity by 138,700,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €408.00 Million +15.02%
Dividends Paid €160.66 Million -5.92%
Share Repurchases €25.05 Million -0.92%
Other Changes €-138.70 Million -5.11%
Total Change €- 3.18%

Book Value vs Market Value Analysis

This analysis compares Modern Dental Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.22x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €2.10 €0.63 x
2018-12-31 €2.00 €0.63 x
2019-12-31 €2.09 €0.63 x
2020-12-31 €2.34 €0.63 x
2021-12-31 €2.45 €0.63 x
2022-12-31 €2.43 €0.63 x
2023-12-31 €2.78 €0.63 x
2024-12-31 €2.88 €0.63 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Modern Dental Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 15.02%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 12.13%
  • • Asset Turnover: 0.83x
  • • Equity Multiplier: 1.50x
  • Recent ROE (15.02%) is above the historical average (9.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 5.59% 6.18% 0.60x 1.51x €-80.09 Million
2017 7.41% 7.12% 0.69x 1.50x €-54.38 Million
2018 4.28% 3.69% 0.75x 1.56x €-114.23 Million
2019 7.99% 6.73% 0.71x 1.66x €-40.52 Million
2020 4.79% 4.92% 0.60x 1.63x €-117.00 Million
2021 15.36% 12.21% 0.81x 1.56x €125.98 Million
2022 9.50% 7.79% 0.80x 1.53x €-11.54 Million
2023 15.35% 12.74% 0.80x 1.50x €140.87 Million
2024 15.02% 12.13% 0.83x 1.50x €136.42 Million

Industry Comparison

This section compares Modern Dental Group Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $10,273,458,961
  • Average return on equity (ROE) among peers: 3.69%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Modern Dental Group Limited (1MD) €3.08 Billion 5.59% 0.43x $193.75 Million
SCHOTT Pharma AG & Co. KGaA (1SXP) $709.04 Million 17.68% 0.69x $482.88 Million
Alcon Inc. (2U3) $19.26 Billion 1.95% 0.45x $33.73 Billion
Shofu Inc. (69W) $35.51 Billion 8.83% 0.23x $215.32 Million
7VG (7VG) $176.36 Million 14.92% 1.12x $684.88 Million
Bio-gate AG (BIG1) $4.25 Million -42.46% 0.46x $2.79 Million
Paul Hartmann AG (PHH2) $690.37 Million 10.65% 0.81x $776.29 Million
Sartorius AG VZO O.N. (SRT) $497.08 Million 9.76% 1.56x $6.78 Billion
Shandong Weigao Group Medical Polymer Company Limited (UK2) $25.34 Billion 8.16% 0.37x $1.36 Billion